Els Boone (@BooneEls) profile picture
Joined October 2019
#ESC2024 @escardio FAME 2: 10-year follow-up 🏪 PCI is 25% more likely to lead to better outcomes than medical therapy alone 🔑 48% of patients were tied. Nearly half the time, it won't make a big difference which one you choose. @PCRonline @CoreAalst @CardioAalst @OptimaCTO
1
25
1
80
5,473
“Hot Line 4 is very important and will probably be the highlight of the Hot Lines for many cardiovascular health professionals. It includes a series of trials – ILUMIEN IV, OCTIVUS and OCTOBER..." @LNAndreasen @h_evald @omeedneghabat @jcspratt #cardotwitter #octfirst
Get ready for #ESCCongress 2023 and discover the highlights from the Hot Line programme 🕒 bit.ly/3YIZeuf #cardiology #cardionews
2
14
1
38
7,116
5-year follow up of DEFINE-FLAIR (iFR vs FFR-guided revascularisation) presented by @JEscaned #EuroPCR2023 ➡️ MACE higher in iFR arm (HR 1.18; CI 0.99 - 1.41, p=0.07) ➡️ All-cause death 3% higher in iFR arm (HR 1.51; CI 1.22 - 2.90) ➡️ Difference driven by CV death
4
34
3
65
38,252
We’d like to take a moment acknowledge Drs. @DDamario, @Vale_Frittitta, and Antonio Greco for their commitment to personalized vascular care. Thank you for sharing your innovative projects aimed at improving #cardiovascular care for patients at #EuroPCR: https://nitter.cf/t.co/YqPjDlo6z7
1
5
1
23
Els Boone retweeted
1/ COMBINE (OCT–FFR): Using OCT in DM to detect risk FFR negative lesions, according to contemporary trial data, are very low risk for subsequent events. BUT...DM patients are a unique entity. What if we could use OCT, with its incredible resolution, to identify high risk - TCFA.
6
21
2
70
Are you prepared for the XIENCE short DAPT program? Stay tuned...coming soon @TCTConference @Drroxmehran @DLBHATTMD